| Biological Sciences | Lifetime | 107 | CN 4 | 99.98 |
| Medical and Health Sciences | Lifetime | 536 | CN 5 | 99.98 |
| Biological Sciences | 2021-2025 | 136 | CN 53 | 99.88 |
| Medical and Health Sciences | 2021-2025 | 516 | CN 55 | 99.89 |
| Psychology and Behavioral Sciences | 2021-2025 | 355 | CN 27 | 99.15 |
| Biological Psychiatry | Lifetime | 1 | CN 1 | 99.85 |
| Psychiatry and Mental health | Lifetime | 41 | CN 1 | 99.88 |
| Behavioral Neuroscience | Lifetime | 10 | CN 1 | 99.80 |
| Clinical Pharmacology | Lifetime | 240 | CN 2 | 99.03 |
| Clinical Psychology | Lifetime | 728 | CN 4 | 98.98 |
| Cognitive Psychology | Lifetime | 736 | CN 8 | 97.66 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 694 | CN 8 | 97.67 |
| Clinical Neurology | Lifetime | 585 | CN 9 | 97.30 |
| Nutrition and Dietetics | Lifetime | 826 | CN 57 | 96.03 |
| Cellular and Molecular Neuroscience | Lifetime | 855 | CN 17 | 95.88 |
| Neuroscience of Neurology | Lifetime | 596 | CN 18 | 94.76 |
| Endocrine and Autonomic Systems | Lifetime | 589 | CN 8 | 88.35 |
| Biological Psychiatry | 2021-2025 | 1 | CN 1 | 99.66 |
| Psychiatry and Mental health | 2021-2025 | 34 | CN 1 | 99.58 |
| Behavioral Neuroscience | 2021-2025 | 4 | CN 1 | 98.15 |
| Clinical Neurology | 2021-2025 | 86 | CN 3 | 98.07 |
| Cognitive Psychology | 2021-2025 | 128 | CN 6 | 97.77 |
| Clinical Psychology | 2021-2025 | 510 | CN 19 | 95.22 |
| Molecular Biology | 2021-2025 | 988 | CN 371 | 94.35 |
| Clinical Biochemistry | 2021-2025 | 52 | CN 6 | 86.46 |
| Cognitive Neuroscience | 2021-2025 | 605 | CN 32 | 87.97 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 1 | CN 1 | 99.90 |
| Long-Term Effects of COVID-19 | Lifetime | 4 | CN 1 | 99.85 |
| Stress Responses and Cortisol | Lifetime | 8 | CN 1 | 99.94 |
| Tryptophan and brain disorders | Lifetime | 9 | CN 1 | 99.92 |
| Health, psychology, and well-being | Lifetime | 11 | CN 1 | 99.72 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 43 | CN 1 | 99.75 |
| Bipolar Disorder and Treatment | Lifetime | 22 | CN 1 | 99.75 |
| Maternal Mental Health During Pregnancy and Postpartum | Lifetime | 45 | CN 1 | 99.42 |
| Treatment of Major Depression | Lifetime | 37 | CN 1 | 99.64 |
| Neuroendocrine regulation and behavior | Lifetime | 78 | CN 2 | 99.43 |
| Diet and metabolism studies | Lifetime | 318 | CN 5 | 99.33 |
| Peptidase Inhibition and Analysis | Lifetime | 274 | CN 4 | 98.84 |
| Mental Health Research Topics | Lifetime | 163 | CN 2 | 99.05 |
| Gut microbiota and health | Lifetime | 386 | CN 31 | 98.70 |
| Schizophrenia research and treatment | Lifetime | 284 | CN 6 | 98.96 |
| Circadian rhythm and melatonin | Lifetime | 221 | CN 2 | 98.26 |
| Dermatology and Skin Diseases | Lifetime | 263 | CN 5 | 98.60 |
| Neuropeptides and Animal Physiology | Lifetime | 484 | CN 10 | 98.31 |
| Alcoholism and Thiamine Deficiency | Lifetime | 79 | CN 1 | 97.24 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 27 | CN 2 | 97.45 |
| Coenzyme Q10 studies and effects | Lifetime | 48 | CN 2 | 97.41 |
| Therapeutic Uses of Natural Elements | Lifetime | 68 | CN 7 | 96.50 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 615 | CN 6 | 97.33 |
| Biochemical Acid Research Studies | Lifetime | 170 | CN 5 | 95.77 |
| Cardiac Health and Mental Health | Lifetime | 617 | CN 10 | 96.17 |
| Fatty Acid Research and Health | Lifetime | 709 | CN 21 | 95.68 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 340 | CN 16 | 93.53 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 825 | CN 6 | 95.02 |
| Exercise and Physiological Responses | Lifetime | 827 | CN 9 | 94.66 |
| Electrolyte and hormonal disorders | Lifetime | 904 | CN 7 | 93.68 |
| Adrenal Hormones and Disorders | Lifetime | 796 | CN 5 | 93.09 |
| Pharmacological Receptor Mechanisms and Effects | Lifetime | 561 | CN 12 | 92.81 |
| Menstrual Health and Disorders | Lifetime | 442 | CN 12 | 87.57 |
| Apelin-related biomedical research | Lifetime | 816 | CN 66 | 85.27 |
| GDF15 and Related Biomarkers | Lifetime | 755 | CN 57 | 76.91 |
| Stress Responses and Cortisol | 2021-2025 | 2 | CN 1 | 99.72 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 2 | CN 1 | 99.65 |
| Long-Term Effects of COVID-19 | 2021-2025 | 20 | CN 1 | 99.56 |
| Tryptophan and brain disorders | 2021-2025 | 9 | CN 1 | 99.67 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 16 | CN 1 | 99.36 |
| Bipolar Disorder and Treatment | 2021-2025 | 25 | CN 1 | 98.55 |
| Mental Health Research Topics | 2021-2025 | 67 | CN 8 | 98.28 |
| Paraoxonase enzyme and polymorphisms | 2021-2025 | 3 | CN 1 | 94.46 |
| Schizophrenia research and treatment | 2021-2025 | 206 | CN 12 | 95.70 |
| Maternal Mental Health During Pregnancy and Postpartum | 2021-2025 | 373 | CN 17 | 92.49 |
| Electrolyte and hormonal disorders | 2021-2025 | 100 | CN 3 | 90.47 |
| Suicide and Self-Harm Studies | 2021-2025 | 879 | CN 67 | 84.09 |
| Vitamin D Research Studies | 2021-2025 | 636 | CN 56 | 78.64 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 763 | CN 24 | 78.84 |
| Folate and B Vitamins Research | 2021-2025 | 522 | CN 142 | 76.21 |
| Coenzyme Q10 studies and effects | 2021-2025 | 91 | CN 14 | 73.52 |
| Menstrual Health and Disorders | 2021-2025 | 288 | CN 22 | 69.42 |
